Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer
A combination of two types of cancer-fighting treatments—the immunotherapy agent pembrolizumab and a nanoparticle-bound form of the chemotherapy drug paclitaxel—may provide an urgently needed new treatment approach for ...
Nov 3, 2022
0
2